Neutra

Neutra Book Value Growth

The Book Value Growth of Neutra (NTRR) as of Oct 22, 2026 is -31.42 %. In the previous year, Book Value Growth was 27.80 % — a change of -213.03% (lower).

Book Value Growth

-31.42 %

YoY

-213.03%

Last updated:

Book Value Growth of Neutra is 2024 -31.42 % . Book Value Growth of Neutra was 2023 27.80 % . It decreases by -213.03% lower compared to the previous year.

The Neutra Book Value Growth history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Book Value Growth
Date
Book Value Growth
Jan 1, 2017
-58.85 USD
Jan 1, 2018
-13.16 USD
Jan 1, 2019
-44.62 USD
Jan 1, 2020
23.16 USD
Jan 1, 2021
4.51 USD
Jan 1, 2022
-26.11 USD
Jan 1, 2023
27.80 USD
Jan 1, 2024
-31.42 USD
The Neutra Book Value Growth history
YEARBook Value GrowthYoY
-31.42 %-213.03%
27.80 %-206.48%
-26.11 %-679.11%
4.51 %-80.54%
23.16 %-151.92%
-44.62 %+239.07%
-13.16 %-77.64%
-58.85 %+478.04%
-10.18 %-144.66%
22.80 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Neutra Stock analysis

What does Neutra do? Neutra Corp. generates revenue by marketing and selling nutraceutical products derived from all natural and organic origins, primarily focusing on the medical cannabis market. The company sells hemp-derived products, including those containing delta-8-THC and other cannabinoids, under its own brand. It entrusts manufacturing to a nutraceutical contractor for private labeling, targeting consumers interested in healthy living solutions. Subsidiaries such as Diamond Anvil Designs, LLC, Deity Corporation, and Vivis Corporation support its operations. The firm's primary customers are consumers seeking natural health products, particularly within the growing nutraceutical sector. Products are sold under the Neutra Corp. brand, emphasizing all-natural and organic origins. The company plans to research new technologies for the nutraceutical space, aiming to expand its product offerings in the medical cannabis sub-market. Neutra Corp. operates in the nutraceutical space by leveraging private-label manufacturing, allowing it to focus on research and development of new technologies. Its product line centers around hemp-derived items, including delta-8-THC products, which are sold directly to end consumers. The company's strategy involves expanding its presence in the medical cannabis market through branded, organic, and natural health solutions. Neutra is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Neutra stock

Book Value Growth of Neutra is -31.42 % in 2024.

On Eulerpool you can find the complete historical development of Book Value Growth Neutra since 2006 – with annual values, charts, and detailed analysis.

Book value growth measures the percentage increase in shareholders' equity. It indicates how effectively the company retains and grows its net assets.

To evaluate Book Value Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Book Value Growth.

Book Value Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Book Value Growth's Neutra historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Growth — Neutra

All Key Metrics — Neutra